_________________
Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934
Date of report (date of earliest event reported): October 28, 2003
ALARIS MEDICAL SYSTEMS, INC. | ||
(Exact name of registrant as specified in its charter) | ||
Delaware | 1-10207 | 13-3492624 |
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
incorporation or organization) | Identification Number) | |
|
||
10221 Wateridge Circle San Diego, CA 92121-1579 |
||
(Address, including zip code, of registrants principal executive offices) | ||
|
||
(858) 458-7000 | ||
Registrants telephone number, including area code |
The following information is being furnished under Item 12, Results of Operations and Financial Condition. Such information,
including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934: On October 28, 2003, ALARIS Medical Systems, Inc. issued the press release attached as Exhibit-99.1, reporting its results for the three months ended September 30, 2003. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ALARIS MEDICAL SYSTEMS, INC. |
Date: October 28, 2003 |
By: /s/ DAVID L. SCHLOTTERBECK David L. Schlotterbeck President and Chief Executive Officer |
Exhibit
99.1 Press release of ALARIS Medical Systems, Inc., dated October 28, 2003, reporting results for three months ended September 30, 2003.